<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02856204</url>
  </required_header>
  <id_info>
    <org_study_id>HEMAML0035</org_study_id>
    <secondary_id>NCI-2016-01128</secondary_id>
    <secondary_id>32817</secondary_id>
    <secondary_id>P30CA124435</secondary_id>
    <nct_id>NCT02856204</nct_id>
  </id_info>
  <brief_title>Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia</brief_title>
  <official_title>Shotgun Sequencing for Etiologic Diagnosis of Febrile Neutropenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      This research trial studies the shotgun sequencing of blood samples in diagnosing febrile
      neutropenia in patients with acute myeloid leukemia. Studying samples of blood from patients
      with acute myeloid leukemia in the laboratory may help identify pathogens and accurately
      diagnose infections such as febrile neutropenia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. To test the hypothesis that shotgun metagenomics is not inferior to standard of care
      diagnostics in the detection of pathogens in patients with febrile neutropenia.

      SECONDARY OBJECTIVES:

      I. To establish a microbiological diagnosis with known or unknown pathogens in patients in
      whom standard care failed to yield a pathogenic diagnosis.

      OUTLINE:

      Patients undergo collection of blood samples before and during the episode of febrile
      neutropenia for up to 6 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of pathogens in patients with febrile neutropenia assessed by shotgun metagenomics</measure>
    <time_frame>Up to 6 weeks</time_frame>
    <description>Will be compared to standard of care diagnostics in the detection of pathogens in patients with febrile neutropenia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number and frequency of novel pathogens found</measure>
    <time_frame>Up to 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients with any pathogen by the standard, where the shotgun did not indicate the presence of the pathogen</measure>
    <time_frame>Up to 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients with false negative</measure>
    <time_frame>Up to 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients with false positives</measure>
    <time_frame>Up to 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients with mitochondrial DNA detected</measure>
    <time_frame>Up to 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiological diagnosis with known or unknown pathogens in patients in whom standard care failed to yield a pathogenic diagnosis assessed by shotgun metagenomics</measure>
    <time_frame>Up to 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Acute Myeloid Leukemia</condition>
  <condition>Febrile Neutropenia</condition>
  <arm_group>
    <arm_group_label>Diagnostic (collection of blood samples)</arm_group_label>
    <description>Patients undergo collection of blood samples before and during the episode of febrile neutropenia for up to 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cytology Specimen Collection Procedure</intervention_name>
    <description>Undergo collection of blood</description>
    <arm_group_label>Diagnostic (collection of blood samples)</arm_group_label>
    <other_name>Cytologic Sampling</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Diagnostic (collection of blood samples)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        hospitalized patients (at Stanford Hospital and Clinics) with acute myelogenous leukemia
        (AML), who are expected to have neutropenia (defined as absolute neutrophil count &lt; 500 /
        cubic mm) lasting â‰¥ 7 days after chemotherapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with febrile neutropenia

          -  A primary diagnosis of acute myeloid leukemia (AML)

        Exclusion Criteria:

          -  Prior history of febrile neutropenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stanley Deresinski</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Coutre</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University, School of Medicine</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanley Deresinski</last_name>
      <email>polishmd@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Esther Benamu</last_name>
      <email>ebenamu@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stanley Deresinski</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Coutre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Brazil</country>
    <country>China</country>
  </removed_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>August 26, 2016</last_update_submitted>
  <last_update_submitted_qc>August 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
    <mesh_term>Neutropenia</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Febrile Neutropenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

